Pain Medicine, Interventional Pain Medicine · Bradenton, FL
NPI
1437110236
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2105 Manatee Ave E
Bradenton, FL, 34208
Phone (941) 803-8395
Groups this clinician bills Medicare through
Medicare paid, 2024
$339K
16,870 services
Medicare patients, 2024
390
Average age 74
Drug cost, 2024
$1.0M
10,783 prescriptions
Company payments, 2025
$1,167
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto J Ycaza was code J0702 (injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg), 3,037 times for 159 patients. In total Roberto J Ycaza billed 16,870 services in 43 codes, and Medicare paid $339K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 3,037 | 159 | $5.38 | $16K |
| 99214 Office E&M - Established | Office | 1,539 | 344 | $95.10 | $146K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,125 | 322 | $12.86 | $14K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 685 | 150 | $0.29 | $198 |
| 80305 Drug Tests | Office | 254 | 229 | $12.25 | $3,112 |
| 99213 Office E&M - Established | Office | 167 | 125 | $60.80 | $10K |
| 99204 Office E&M - New | Office | 137 | 137 | $119.92 | $16K |
| 20610 Joint Injection | Office | 122 | 61 | $57.29 | $6,989 |
| 64483 Nerve Block Injection - Back | Office | 119 | 75 | $213.90 | $25K |
| 77002 Imaging - Miscellaneous | Office | 115 | 59 | $86.61 | $9,960 |
| 64484 Nerve Block Injection - Back | Office | 87 | 58 | $91.37 | $7,950 |
| 64494 Nerve Block Injection - Back | Office | 75 | 48 | $72.10 | $5,407 |
| 64493 Nerve Block Injection - Back | Office | 75 | 48 | $138.95 | $10K |
| 27096 Joint Injection | Office | 58 | 39 | $135.04 | $7,833 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 40 | 35 | $156.38 | $6,255 |
By year: 2022 $276K for 13,898 services; 2023 $700K for 15,246 services; 2024 $339K for 16,870 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 254 | 229 | $12.25 | $3,112 |
Medicare prescription drug claims, 2024
In 2024, the drug Roberto J Ycaza prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,241 prescriptions and refills. In total Roberto J Ycaza wrote 10,783 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,241 | 2,242 | 333 | $59K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,512 | 1,513 | 213 | $60K |
| Oxycodone Hcl Generic | 1,223 | 1,224 | 147 | $26K |
| Morphine Sulfate Er Morphine Sulfate | 872 | 872 | 95 | $22K |
| Pregabalin Generic | 788 | 827 | 177 | $23K |
| Tramadol Hcl Generic | 629 | 632 | 126 | $6,112 |
| Gabapentin Generic | 426 | 519 | 95 | $6,098 |
| Tramadol Hcl Er Tramadol Hcl | 360 | 360 | 59 | $22K |
| Morphine Sulfate Generic | 293 | 293 | 32 | $10K |
| Xtampza Er Oxycodone Myristate | 236 | 246 | 32 | $146K |
| Tizanidine Hcl Generic | 214 | 279 | 53 | $2,403 |
| Fentanyl Generic | 128 | 128 | 14 | $9,533 |
| Methadone Hcl Generic | 127 | 127 | 12 | $2,990 |
| Hydromorphone Hcl Generic | 115 | 115 | 17 | $3,340 |
| Duloxetine Hcl Generic | 101 | 157 | 24 | $3,096 |
Brand drugs: - claims; generic drugs: 9,832 claims; opioid claims: 8,017.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto J Ycaza $1,167 ($1,167 in general payments such as food, travel and fees) from 16 companies. The largest payer was Boston Scientific Corporation with $208.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 5 | $208 |
| Collegium Pharmaceutical, Inc. COLL | 5 | $111 |
| Globus Medical, Inc. GMED | 5 | $110 |
| Abbvie Inc. ABBV | 5 | $104 |
| Dornier MedTech America, Inc | 1 | $100 |
| Saluda Medical Americas, Inc. | 3 | $92.75 |
| Amgen Inc. AMGN | 4 | $79.37 |
| Stryker Corporation SYK | 2 | $71.8 |
| Radius Health, Inc. | 3 | $67.82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $59.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.